Cybersecurity clauses become a standard part of device contracts

Procurement documents for connected medical devices increasingly include cybersecurity requirements that go beyond a declaration of conformity. Buyers ask for a software bill of materials, a defined vulnerability disclosure process, and a commitment to provide security patches for a stated support period. In some markets these requirements are now scored, so a weak answer costs points in the evaluation rather than simply prompting a clarification question.

Suppliers have had to convert engineering practice into contractual language. A typical clause now specifies the maximum time to acknowledge a critical vulnerability, the time to release a mitigation, and the conditions under which a patch can be deferred because it requires revalidation of the device. Legal and quality teams that previously worked separately now review the same document before a tender is submitted.

The support period is the most contested item. Hospitals want cover for the full expected service life, which for imaging systems can exceed ten years. Manufacturers point out that operating system vendors and third-party libraries drop support on their own schedules, and that maintaining an unsupported platform carries its own risk. Neither position is unreasonable, which is why negotiations tend to stall at this point.

The workable compromise being adopted in several markets is a published end-of-support date at the point of sale, plus a documented migration path. That gives biomedical engineering departments something concrete to plan against, rather than an open-ended assurance that is difficult to audit, and it allows the hospital to budget for replacement before the device becomes an unpatched liability inside a clinical network.